FindTrial
Sign In

A study to test if Santoninum 30C helps treat worm infections in children, using a dummy treatment for comparison

A RANDOMIZED SINGLE BLIND, PLACEBO CONTROLLED TRIAL TO ASSESS THE EFFECTIVENESS OF SANTONINUM 30C IN CASES OF WORM INFESTATION IN PAEDIATRIC AGE GROUP - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093782
Enrollment
80
Registered
2025-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B839- Helminthiasis, unspecified

Interventions

Intervention1: SANTONINUM 30C: Group A- MEDICINE - SANTONINUM will be prescribed. POTENCY ? 30 C is being fixed Dosage: Dosage as per susceptibility of the patient using 6 medicated globules per dos

Sponsors

Swasthya Kalyan Homeopathic and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient coming from other mode of treatment with no relief.

Exclusion criteria

Exclusion criteria: 1. Cases which require emergency treatment. 2. Above 18 years 3. Cases which need surgical intervention. 4. Immuno compromised patient such as suffering from HIV, Hepatitis B C etc. 5. Cases with multi systemic illness and cases with advance pathology will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
The homoeopathic management with santoninum 30c will be proven beneficial in the treatment of Worm infestation in paediatric age group.Timepoint: 12 months—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Shobha Teterwal

Swasthya kalyan Homeopathic College and Research Centre

Shobhateterwal@gmail.com07976638807

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026